Comtech Stampede FX-1010 7.4.3 Diagnostics Trace Route Page Shell Metacharacter os command injection
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 6.7 | $0-$5k | 0.00 |
Summary
A vulnerability marked as critical has been reported in Comtech Stampede FX-1010 7.4.3. Affected by this issue is some unknown functionality of the component Diagnostics Trace Route Page. Performing a manipulation as part of Shell Metacharacter results in os command injection. This vulnerability is cataloged as CVE-2020-7242. It is possible to initiate the attack remotely. There is no exploit available.
Details
A vulnerability classified as critical has been found in Comtech Stampede FX-1010 7.4.3. This affects an unknown code of the component Diagnostics Trace Route Page. The manipulation as part of a Shell Metacharacter leads to a os command injection vulnerability. CWE is classifying the issue as CWE-78. The product constructs all or part of an OS command using externally-influenced input from an upstream component, but it does not neutralize or incorrectly neutralizes special elements that could modify the intended OS command when it is sent to a downstream component. This is going to have an impact on confidentiality, integrity, and availability. The summary by CVE is:
Comtech Stampede FX-1010 7.4.3 devices allow remote authenticated administrators to achieve remote code execution by navigating to the Diagnostics Trace Route page and entering shell metacharacters in the Target IP address field. (In some cases, authentication can be achieved with the comtech password for the comtech account.)
The weakness was shared 01/20/2020. This vulnerability is uniquely identified as CVE-2020-7242 since 01/20/2020. It is possible to initiate the attack remotely. A authentication is needed for exploitation. The technical details are unknown and an exploit is not publicly available. The attack technique deployed by this issue is T1202 according to MITRE ATT&CK.
There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.
The entries VDB-149141 and VDB-149140 are related to this item. Statistical analysis made it clear that VulDB provides the best quality for vulnerability data.
Product
Vendor
Name
Version
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 6.7VulDB Meta Temp Score: 6.7
VulDB Base Score: 6.3
VulDB Temp Score: 6.3
VulDB Vector: 🔍
VulDB Reliability: 🔍
NVD Base Score: 7.2
NVD Vector: 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
NVD Base Score: 🔍
Exploiting
Class: Os command injectionCWE: CWE-78 / CWE-77 / CWE-74
CAPEC: 🔍
ATT&CK: 🔍
Physical: No
Local: No
Remote: Yes
Availability: 🔍
Status: Not defined
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
0-Day Time: 🔍
Timeline
01/20/2020 🔍01/20/2020 🔍
01/21/2020 🔍
01/02/2026 🔍
Sources
Advisory: sku11army.blogspot.comStatus: Not defined
CVE: CVE-2020-7242 (🔍)
GCVE (CVE): GCVE-0-2020-7242
GCVE (VulDB): GCVE-100-149139
See also: 🔍
Entry
Created: 01/21/2020 07:55Updated: 01/02/2026 16:09
Changes: 01/21/2020 07:55 (37), 01/21/2020 08:00 (17), 03/25/2024 06:46 (17), 01/02/2026 16:09 (1)
Complete: 🔍
Cache ID: 216::103
Statistical analysis made it clear that VulDB provides the best quality for vulnerability data.
No comments yet. Languages: en.
Please log in to comment.